Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy

Update Il y a 4 ans
Reference: NCT00251680

Woman and Man

Extract

The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with established lipid-lowering therapy in subjects with type 2 diabetes mellitus.


Inclusion criteria

  • Type 2 Diabetes


Links